| Sanofi-Aventis (Suisse) SA - Suliqua 100/33, solution injectable |
| 66283 | | 02 | | Suliqua 100/33 | | solution injectable | | A10AE54 | | Insulin Glargine and Lixisenatide | | 05.10.2017 | | |
|
| Composition |
| insulinum glarginum 3.64 mg corresp. insulinum glarginum 100 U., lixisenatidum 33 µg, zinci chloridum, glycerolum (85 per centum), methioninum, conserv.: metacresolum 2.7 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. |
| Packungsbestandteile |
| Solution injectable | | | | | | | | Principe actif | Concentr. |
|---|
| Insuline Glargine | 3.64 mg/ml correspond Insuline Glargine 100 U/ml | | Lixisenatidum | 33 µg/ml |
| | BAG: Principe actif | Concentr. |
|---|
| Insuline Glargine | 100 U | | Lixisenatidum | 33 mcg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Glycerol | | | | Metacresol | 2.7 mg/ml | conserv. | | Methionine | | | | Zinci Chlorure | | |
| |
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 003 | 3 | 70.76 | 93.35 | B | LS | Oui |
|
